Note: Ingredients listed on restricted chemical lists
EC/CAS
182442-95-1
Name of the chemical
Cobalt lithium manganese nickel oxide
Concentration
N/A
EC/CAS
231-955-3/7782-42-5
Name of the chemical
Graphite
Concentration
N/A
EC/CAS
618-470-6/9011-17-0
Name of the chemical
1,1-Difluorethylene-hexafluorpropene polymer
Concentration
N/A
EC/CAS
231-072-3/7429-90-5
Name of the chemical
Aluminium
Concentration
N/A
EC/CAS
231-159-6/7440-50-8
Name of the chemical
Copper
Concentration
N/A
EC/CAS
202-510-0/96-49-1
Name of the chemical
ethylene carbonate
Concentration
N/A
EC/CAS
210-478-4/616-38-6
Name of the chemical
dimethyl carbonate
Concentration
N/A
EC/CAS
215-609-9/1333-86-4
Name of the chemical
carbon black
Concentration
640-3
General Information
Revision date
2022-08-31
Product name
Li-ion Battery Pack
1.2.1 Relevant identified uses
Power supply
Manufacturer Name
EVE Hyperpower Lithium Batteries Inc
Emergency telephone
86-13828810395
Icons in SDS
Company Information
company name
EVE Hyperpower Lithium Batteries Inc
e-mail address of the competent person responsible for the Safety Data Sheet
048723@evebattery.com
GHS Information
Signal word
None
Section 2
SECTION 2: Hazards identification
According to Regulation (EC) No. 1272/2008 (CLP) Classification of the substance or mixture
Adverse physicochemical, human health and environmental effects
To our knowledge, this product does not present any particular risk, provided it is handled in accordance with good occupational hygiene and safety practice
Hazard pictograms
None
Signal word
None
Hazard statements
Not applicable
Precautionary statements
Not applicable
Supplemental label elements
None.
PBT Substances
not yet assessed
vPvB Substances
not yet assessed Contains no PBT/vPvB substances ≥ 0.1% assessed in accordance with REACH Annex XIII The mixtures is not included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605
2.1 Classification of the substance or mixture
Classification according to Regulation (EC) No. 1272/2008 [CLP] Not classified Adverse physicochemical, human health and environmental effects To our knowledge, this product does not present any particular risk, provided it is handled in accordance with good occupational hygiene and safety practice. 2.2. Label elements Labelling according to Regulation (EC) No. 1272/2008 [CLP] Hazard pictograms (CLP) : None Signal word (CLP) : None Hazard statements (CLP) : Not applicable Precautionary statements (CLP) : Not applicable EUH-statements : None. 2.3. Other hazards PBT: not yet assessed vPvB: not yet assessed Contains no PBT/vPvB substances ≥ 0.1% assessed in accordance with REACH Annex XIII The mixtures is not included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 SECTION 3: Composition/information on ingredients 3.1. Substances Not applicable. 3.2. Mixtures Name
